Vectus Biosystems (ASX:VBS) Accounts Payable : A$0.22 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Vectus Biosystems Accounts Payable?

Vectus Biosystems's Accounts Payable for the quarter that ended in Dec. 2023 was A$0.22 Mil.

Vectus Biosystems's quarterly Accounts Payable increased from Dec. 2022 (A$0.16 Mil) to Jun. 2023 (A$0.22 Mil) but then declined from Jun. 2023 (A$0.22 Mil) to Dec. 2023 (A$0.22 Mil).

Vectus Biosystems's annual Accounts Payable declined from Jun. 2021 (A$0.33 Mil) to Jun. 2022 (A$0.12 Mil) but then increased from Jun. 2022 (A$0.12 Mil) to Jun. 2023 (A$0.22 Mil).

Vectus Biosystems Accounts Payable Historical Data

The historical data trend for Vectus Biosystems's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Accounts Payable Chart

Vectus Biosystems Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable

Get a 7-Day Free Trial

1.12

0.61

0.33

0.12

0.22

Vectus Biosystems Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial											0.76	0.12	0.16	0.22	0.22

Vectus Biosystems Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Vectus Biosystems Accounts Payable Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Vectus Biosystems (ASX:VBS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018

Website

https://www.vectusbiosystems.com.au

Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines